CD4 T cells and anti-viral control in SIV infection
SIV 感染中的 CD4 T 细胞和抗病毒控制
基本信息
- 批准号:7167875
- 负责人:
- 金额:$ 16.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAnimal ModelAnimalsAnti-Retroviral AgentsAntigensAntiviral ResponseAutologousBiological AssayBiological PreservationBloodCD4 Positive T LymphocytesCD8B1 geneCell CountCell Cycle KineticsCell Differentiation processCellsClinicalColorCoupledDiseaseEvolutionExhibitsFlow CytometryFrequenciesGaggingGenerationsHIVHighly Active Antiretroviral TherapyHourImmune responseImmune systemImmunological ModelsIndividualInfectionInfection ControlInterleukin-2LeadLongevityLymphocytic choriomeningitis virusMacaca mulattaMaintenanceMeasuresMediatingMesenteryModelingMolecularMucous MembraneMusNatural regenerationNatureOutcomePeptidesPeripheralPhasePlayPrincipal InvestigatorProliferatingResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleSIVSamplingShapesSimplexvirusSorting - Cell MovementStaining methodStainsSubfamily lentivirinaeSymptomsSyndromeT-LymphocyteT-Lymphocyte SubsetsTNFRSF5 geneTNFRSF6 geneTNFSF5 geneTechniquesTherapeuticTissue PreservationTissuesViralViral Load resultViremiaVirus DiseasesWeekbaseinsightjejunumlymph nodesmemory CD4 T lymphocytepathogenpeptide Vpinacolyl methylphosphonic acidpol genespreventprogramsresponsevirus pathogenesis
项目摘要
DESCRIPTION (provided by applicant): HIV infection is characterized by an extensive loss of CD4 T cells very early during infection. This coupled with the demonstration that HIV specific CD4 T cell are preferentially infected and destroyed during the course of HIV infection suggests that the ability of the immune system to generate anti-viral immune responses to control HIV is severely compromised very early during HIV infection. Recent studies in small animal modes and HIV infected subjects treated with anti-retroviral therapy (ART) during primary infection indicate that early loss of CD4 T cells may have significant implications for the generation and maintenance of anti-viral CDS T cell responses. The exact role of CD4 T cells in CDS mediated control of HIV infection has not been completely delineated. The long term objectives of this study are to delineate the role of CD4 T cell help in the generation of anti-viral immune responses, and to determine how these responses correlate with durable control of infection and long term outcome. The Specific Aims of this proposal are (1) to determine if early initiation of ART can preserve CD4 T cells in peripheral and mucosal tissues, and if this preservation correlates with qualitative changes in the nature of anti-viral CDS T cell responses (2) to examine if the qualitative differences in the nature of CDS T cell responses correlate with durable viral control and favorable long term outcome after cessation of ART. We hypothesize that early ART will preserve CD4 T cells that in turn will lead to generation of stronger and more effective poly functional CDS T cell responses that will aid in better control of viral infection. Rhesus macaques infected with SIVmac239 and treated with PMPA and FTC will be used in this study. The degree of CD4 T cell preservation in both peripheral and mucosal tissues after ART will be determined using multi-color flow cytometry and molecular techniques. SIV specific CDS T cell responses will be evaluated by measuring multiple functional markers simultaneously using intracellular staining and multi-color flow cytometry. These studies will provide extremely valuable insights into the role of CD4 T cells in CDS mediated control of HIV infection, and will help develop better therapeutic approaches for durable control of HIV infection.
描述(由申请人提供):艾滋病毒感染的特征是在感染过程中很早就丧失了CD4 T细胞。结合以下证明,在HIV感染过程中,HIV特异性CD4 T细胞优先被感染和破坏,这表明免疫系统在HIV感染期间很早就严重损害了免疫系统对控制HIV的抗病毒免疫反应的能力。在原发性感染期间,在接受抗逆转录病毒治疗(ART)治疗的小动物模式和艾滋病毒感染受试者中的最新研究表明,CD4 T细胞的早期丧失可能对抗病毒CDS T细胞反应的产生和维持可能具有重要意义。 CD4 T细胞在CDS介导的HIV感染的控制中的确切作用尚未完全描述。这项研究的长期目标是描述CD4 T细胞在产生抗病毒免疫反应中的作用,并确定这些反应与感染和长期结局的持久控制如何相关。该提案的具体目的是(1)确定艺术的早期开始是否可以保留外周和粘膜组织中的CD4 T细胞,以及该保存是否与抗病毒CDS T细胞反应性质的质量变化相关(2),以检查CDS T细胞在CDS T细胞性质上是否与持久性的术语相关,并在持久的术语中是否具有良好的术语和术语相关。我们假设早期ART将保留CD4 T细胞,而CD4 T细胞反过来会导致产生更强大,更有效的多功能CDS T细胞反应,从而有助于更好地控制病毒感染。本研究将使用感染SIVMAC239并用PMPA和FTC处理的恒河猕猴。使用多色流式细胞仪和分子技术,将确定ART后外周血和粘膜组织中CD4 T细胞的保存程度。 SIV特异性CD T细胞反应将通过使用细胞内染色和多色流式细胞仪同时测量多个功能标记来评估。这些研究将提供对CD4 T细胞在CDS介导的HIV感染控制中的作用的极为宝贵的见解,并将有助于开发更好的治疗方法,以持久控制HIV感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph John Mattapallil其他文献
Joseph John Mattapallil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph John Mattapallil', 18)}}的其他基金
Development of the ferret model for EV-D68 infection
EV-D68感染雪貂模型的开发
- 批准号:
9978480 - 财政年份:2020
- 资助金额:
$ 16.2万 - 项目类别:
Development of the ferret model for EV-D68 infection
EV-D68感染雪貂模型的开发
- 批准号:
10256642 - 财政年份:2020
- 资助金额:
$ 16.2万 - 项目类别:
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy
粘膜上皮和长期抗逆转录病毒治疗
- 批准号:
7277094 - 财政年份:2007
- 资助金额:
$ 16.2万 - 项目类别:
CD4 T cells and anti-viral control in SIV infection
SIV 感染中的 CD4 T 细胞和抗病毒控制
- 批准号:
7344795 - 财政年份:2007
- 资助金额:
$ 16.2万 - 项目类别:
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy
粘膜上皮和长期抗逆转录病毒治疗
- 批准号:
7367168 - 财政年份:2007
- 资助金额:
$ 16.2万 - 项目类别:
Mucosal Epithelium and Long-Term Anti-Retroviral Therapy
粘膜上皮和长期抗逆转录病毒治疗
- 批准号:
7681385 - 财政年份:2007
- 资助金额:
$ 16.2万 - 项目类别:
相似国自然基金
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
- 批准号:
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:专项基金项目
树鼩异种移植模型的建立及免疫排斥机制的深入研究
- 批准号:81771721
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
染色体大片段缺失的急性髓性白血病动物模型的构建及分析
- 批准号:81770157
- 批准年份:2017
- 资助金额:84.0 万元
- 项目类别:面上项目
应用人工泵肺改善急性心梗心源性休克预后及心室重构机制研究
- 批准号:81500319
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
在 ART 开始时进行早期抗增殖治疗干预,以限制 SIV 的长期持续存在
- 批准号:
10849960 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别: